Industry Research Reports

Home > Reports > Food & Beverages > Bioactive Protein and Peptides - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Bioactive Protein and Peptides - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Food & Beverages

Published: 2024-01-18

Pages: 131 Pages

Report ld: 2325471

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Bioactive proteins and peptides are considered as important ingredients in functional foods, nutraceuticals and personal care. The roles of bioactive proteins and peptides include antioxidant, antimicrobial, antihypertensive, immunomodulatory and other biological activities.

The global market for Bioactive Protein and Peptides was estimated to be worth US$ 1695.8 million in 2023 and is forecast to a readjusted size of US$ 2706.1 million by 2030 with a CAGR of 6.9% during the forecast period 2024-2030

Bioactive Protein and Peptides Market Size

M= millions and B=billions

Global key players of bioactive protein and peptides include Gelita, Kerry Group, Vital Proteins, Rousselot, BRF Ingredients, etc. The top five players hold a share over 50%. North America is the largest market, has a share about 40%, followed by Europe, and Asia-Pacific, with share 30% and 20%, separately.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Bioactive Protein and Peptides, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Bioactive Protein and Peptides by region & country, by Source, and by Application.

The Bioactive Protein and Peptides market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioactive Protein and Peptides.

Market Segmentation

Report Metric
Details
Report Title
Bioactive Protein and Peptides - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 2706.1 million
CAGR(2024-2030)
6.9%
Market Size Available for Years
2019-2030
Global Bioactive Protein and Peptides Companies Covered
Gelita, Kerry Group, Vital Proteins, Rousselot, BRF Ingredients, Bunge Ltd, Ingredia Nutritional, Gelatines Weishardt, PanTheryx, Hubei Reborn Biotech, Seagarden, Shandong Hengxin Biotech, Baotou Dongbao Bio-Tech, Wuhan Jiushengtang Biotech, Morinaga Milk, Collagile, Nuritas, SmartPEP
Global Bioactive Protein and Peptides Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bioactive Protein and Peptides Market, Segment by Type
Plant Source

Animal Source
Global Bioactive Protein and Peptides Market, Segment by Application
Functional Food

Dietary Supplements

Personal Care

Animal Nutrition

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bioactive Protein and Peptides manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Source, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Bioactive Protein and Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Bioactive Protein and Peptides in country level. It provides sigmate data by Source, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Bioactive Protein and Peptides Product Introduction
    1.2 Global Bioactive Protein and Peptides Market Size Forecast
    1.3 Bioactive Protein and Peptides Market Trends & Drivers
        1.3.1 Bioactive Protein and Peptides Industry Trends
        1.3.2 Bioactive Protein and Peptides Market Drivers & Opportunity
        1.3.3 Bioactive Protein and Peptides Market Challenges
        1.3.4 Bioactive Protein and Peptides Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Bioactive Protein and Peptides Players Revenue Ranking (2023)
    2.2 Global Bioactive Protein and Peptides Revenue by Company (2019-2024)
    2.3 Key Companies Bioactive Protein and Peptides Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Bioactive Protein and Peptides Product Offered
    2.5 Key Companies Time to Begin Mass Production of Bioactive Protein and Peptides
    2.6 Bioactive Protein and Peptides Market Competitive Analysis
        2.6.1 Bioactive Protein and Peptides Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Bioactive Protein and Peptides Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioactive Protein and Peptides as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Source
    3.1 Introduction by Source
        3.1.1 Plant Source
        3.1.2 Animal Source
    3.2 Global Bioactive Protein and Peptides Sales Value by Source
        3.2.1 Global Bioactive Protein and Peptides Sales Value by Source (2019 VS 2023 VS 2030)
        3.2.2 Global Bioactive Protein and Peptides Sales Value, by Source (2019-2030)
        3.2.3 Global Bioactive Protein and Peptides Sales Value, by Source (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Functional Food
        4.1.2 Dietary Supplements
        4.1.3 Personal Care
        4.1.4 Animal Nutrition
        4.1.5 Other
    4.2 Global Bioactive Protein and Peptides Sales Value by Application
        4.2.1 Global Bioactive Protein and Peptides Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Bioactive Protein and Peptides Sales Value, by Application (2019-2030)
        4.2.3 Global Bioactive Protein and Peptides Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Bioactive Protein and Peptides Sales Value by Region
        5.1.1 Global Bioactive Protein and Peptides Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Bioactive Protein and Peptides Sales Value by Region (2019-2024)
        5.1.3 Global Bioactive Protein and Peptides Sales Value by Region (2025-2030)
        5.1.4 Global Bioactive Protein and Peptides Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Bioactive Protein and Peptides Sales Value, 2019-2030
        5.2.2 North America Bioactive Protein and Peptides Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Bioactive Protein and Peptides Sales Value, 2019-2030
        5.3.2 Europe Bioactive Protein and Peptides Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Bioactive Protein and Peptides Sales Value, 2019-2030
        5.4.2 Asia Pacific Bioactive Protein and Peptides Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Bioactive Protein and Peptides Sales Value, 2019-2030
        5.5.2 South America Bioactive Protein and Peptides Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Bioactive Protein and Peptides Sales Value, 2019-2030
        5.6.2 Middle East & Africa Bioactive Protein and Peptides Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Bioactive Protein and Peptides Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Bioactive Protein and Peptides Sales Value
    6.3 United States
        6.3.1 United States Bioactive Protein and Peptides Sales Value, 2019-2030
        6.3.2 United States Bioactive Protein and Peptides Sales Value by Source (%), 2023 VS 2030
        6.3.3 United States Bioactive Protein and Peptides Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Bioactive Protein and Peptides Sales Value, 2019-2030
        6.4.2 Europe Bioactive Protein and Peptides Sales Value by Source (%), 2023 VS 2030
        6.4.3 Europe Bioactive Protein and Peptides Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Bioactive Protein and Peptides Sales Value, 2019-2030
        6.5.2 China Bioactive Protein and Peptides Sales Value by Source (%), 2023 VS 2030
        6.5.3 China Bioactive Protein and Peptides Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Bioactive Protein and Peptides Sales Value, 2019-2030
        6.6.2 Japan Bioactive Protein and Peptides Sales Value by Source (%), 2023 VS 2030
        6.6.3 Japan Bioactive Protein and Peptides Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Bioactive Protein and Peptides Sales Value, 2019-2030
        6.7.2 South Korea Bioactive Protein and Peptides Sales Value by Source (%), 2023 VS 2030
        6.7.3 South Korea Bioactive Protein and Peptides Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Bioactive Protein and Peptides Sales Value, 2019-2030
        6.8.2 Southeast Asia Bioactive Protein and Peptides Sales Value by Source (%), 2023 VS 2030
        6.8.3 Southeast Asia Bioactive Protein and Peptides Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Bioactive Protein and Peptides Sales Value, 2019-2030
        6.9.2 India Bioactive Protein and Peptides Sales Value by Source (%), 2023 VS 2030
        6.9.3 India Bioactive Protein and Peptides Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Gelita
        7.1.1 Gelita Profile
        7.1.2 Gelita Main Business
        7.1.3 Gelita Bioactive Protein and Peptides Products, Services and Solutions
        7.1.4 Gelita Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.1.5 Gelita Recent Developments
    7.2 Kerry Group
        7.2.1 Kerry Group Profile
        7.2.2 Kerry Group Main Business
        7.2.3 Kerry Group Bioactive Protein and Peptides Products, Services and Solutions
        7.2.4 Kerry Group Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.2.5 Kerry Group Recent Developments
    7.3 Vital Proteins
        7.3.1 Vital Proteins Profile
        7.3.2 Vital Proteins Main Business
        7.3.3 Vital Proteins Bioactive Protein and Peptides Products, Services and Solutions
        7.3.4 Vital Proteins Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.3.5 Rousselot Recent Developments
    7.4 Rousselot
        7.4.1 Rousselot Profile
        7.4.2 Rousselot Main Business
        7.4.3 Rousselot Bioactive Protein and Peptides Products, Services and Solutions
        7.4.4 Rousselot Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.4.5 Rousselot Recent Developments
    7.5 BRF Ingredients
        7.5.1 BRF Ingredients Profile
        7.5.2 BRF Ingredients Main Business
        7.5.3 BRF Ingredients Bioactive Protein and Peptides Products, Services and Solutions
        7.5.4 BRF Ingredients Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.5.5 BRF Ingredients Recent Developments
    7.6 Bunge Ltd
        7.6.1 Bunge Ltd Profile
        7.6.2 Bunge Ltd Main Business
        7.6.3 Bunge Ltd Bioactive Protein and Peptides Products, Services and Solutions
        7.6.4 Bunge Ltd Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.6.5 Bunge Ltd Recent Developments
    7.7 Ingredia Nutritional
        7.7.1 Ingredia Nutritional Profile
        7.7.2 Ingredia Nutritional Main Business
        7.7.3 Ingredia Nutritional Bioactive Protein and Peptides Products, Services and Solutions
        7.7.4 Ingredia Nutritional Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.7.5 Ingredia Nutritional Recent Developments
    7.8 Gelatines Weishardt
        7.8.1 Gelatines Weishardt Profile
        7.8.2 Gelatines Weishardt Main Business
        7.8.3 Gelatines Weishardt Bioactive Protein and Peptides Products, Services and Solutions
        7.8.4 Gelatines Weishardt Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.8.5 Gelatines Weishardt Recent Developments
    7.9 PanTheryx
        7.9.1 PanTheryx Profile
        7.9.2 PanTheryx Main Business
        7.9.3 PanTheryx Bioactive Protein and Peptides Products, Services and Solutions
        7.9.4 PanTheryx Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.9.5 PanTheryx Recent Developments
    7.10 Hubei Reborn Biotech
        7.10.1 Hubei Reborn Biotech Profile
        7.10.2 Hubei Reborn Biotech Main Business
        7.10.3 Hubei Reborn Biotech Bioactive Protein and Peptides Products, Services and Solutions
        7.10.4 Hubei Reborn Biotech Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.10.5 Hubei Reborn Biotech Recent Developments
    7.11 Seagarden
        7.11.1 Seagarden Profile
        7.11.2 Seagarden Main Business
        7.11.3 Seagarden Bioactive Protein and Peptides Products, Services and Solutions
        7.11.4 Seagarden Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.11.5 Seagarden Recent Developments
    7.12 Shandong Hengxin Biotech
        7.12.1 Shandong Hengxin Biotech Profile
        7.12.2 Shandong Hengxin Biotech Main Business
        7.12.3 Shandong Hengxin Biotech Bioactive Protein and Peptides Products, Services and Solutions
        7.12.4 Shandong Hengxin Biotech Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.12.5 Shandong Hengxin Biotech Recent Developments
    7.13 Baotou Dongbao Bio-Tech
        7.13.1 Baotou Dongbao Bio-Tech Profile
        7.13.2 Baotou Dongbao Bio-Tech Main Business
        7.13.3 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Products, Services and Solutions
        7.13.4 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.13.5 Baotou Dongbao Bio-Tech Recent Developments
    7.14 Wuhan Jiushengtang Biotech
        7.14.1 Wuhan Jiushengtang Biotech Profile
        7.14.2 Wuhan Jiushengtang Biotech Main Business
        7.14.3 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Products, Services and Solutions
        7.14.4 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.14.5 Wuhan Jiushengtang Biotech Recent Developments
    7.15 Morinaga Milk
        7.15.1 Morinaga Milk Profile
        7.15.2 Morinaga Milk Main Business
        7.15.3 Morinaga Milk Bioactive Protein and Peptides Products, Services and Solutions
        7.15.4 Morinaga Milk Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.15.5 Morinaga Milk Recent Developments
    7.16 Collagile
        7.16.1 Collagile Profile
        7.16.2 Collagile Main Business
        7.16.3 Collagile Bioactive Protein and Peptides Products, Services and Solutions
        7.16.4 Collagile Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.16.5 Collagile Recent Developments
    7.17 Nuritas
        7.17.1 Nuritas Profile
        7.17.2 Nuritas Main Business
        7.17.3 Nuritas Bioactive Protein and Peptides Products, Services and Solutions
        7.17.4 Nuritas Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.17.5 Nuritas Recent Developments
    7.18 SmartPEP
        7.18.1 SmartPEP Profile
        7.18.2 SmartPEP Main Business
        7.18.3 SmartPEP Bioactive Protein and Peptides Products, Services and Solutions
        7.18.4 SmartPEP Bioactive Protein and Peptides Revenue (US$ Million) & (2019-2024)
        7.18.5 SmartPEP Recent Developments

 8 Industry Chain Analysis
    8.1 Bioactive Protein and Peptides Industrial Chain
    8.2 Bioactive Protein and Peptides Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Bioactive Protein and Peptides Sales Model
        8.5.2 Sales Channel
        8.5.3 Bioactive Protein and Peptides Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Bioactive Protein and Peptides Market Trends
    Table 2. Bioactive Protein and Peptides Market Drivers & Opportunity
    Table 3. Bioactive Protein and Peptides Market Challenges
    Table 4. Bioactive Protein and Peptides Market Restraints
    Table 5. Global Bioactive Protein and Peptides Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Bioactive Protein and Peptides Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Bioactive Protein and Peptides Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Bioactive Protein and Peptides Product Type
    Table 9. Key Companies Time to Begin Mass Production of Bioactive Protein and Peptides
    Table 10. Global Bioactive Protein and Peptides Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioactive Protein and Peptides as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Bioactive Protein and Peptides Sales Value by Source: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Bioactive Protein and Peptides Sales Value by Source (2019-2024) & (US$ Million)
    Table 15. Global Bioactive Protein and Peptides Sales Value by Source (2025-2030) & (US$ Million)
    Table 16. Global Bioactive Protein and Peptides Sales Market Share in Value by Source (2019-2024) & (%)
    Table 17. Global Bioactive Protein and Peptides Sales Market Share in Value by Source (2025-2030) & (%)
    Table 18. Global Bioactive Protein and Peptides Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Bioactive Protein and Peptides Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Bioactive Protein and Peptides Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Bioactive Protein and Peptides Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Bioactive Protein and Peptides Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Bioactive Protein and Peptides Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Bioactive Protein and Peptides Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Bioactive Protein and Peptides Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Bioactive Protein and Peptides Sales Value by Region (2019-2024) & (%)
    Table 27. Global Bioactive Protein and Peptides Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Bioactive Protein and Peptides Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Bioactive Protein and Peptides Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Bioactive Protein and Peptides Sales Value, (2025-2030) & (US$ Million)
    Table 31. Gelita Basic Information List
    Table 32. Gelita Description and Business Overview
    Table 33. Gelita Bioactive Protein and Peptides Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Bioactive Protein and Peptides Business of Gelita (2019-2024)
    Table 35. Gelita Recent Developments
    Table 36. Kerry Group Basic Information List
    Table 37. Kerry Group Description and Business Overview
    Table 38. Kerry Group Bioactive Protein and Peptides Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Bioactive Protein and Peptides Business of Kerry Group (2019-2024)
    Table 40. Kerry Group Recent Developments
    Table 41. Vital Proteins Basic Information List
    Table 42. Vital Proteins Description and Business Overview
    Table 43. Vital Proteins Bioactive Protein and Peptides Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Bioactive Protein and Peptides Business of Vital Proteins (2019-2024)
    Table 45. Vital Proteins Recent Developments
    Table 46. Rousselot Basic Information List
    Table 47. Rousselot Description and Business Overview
    Table 48. Rousselot Bioactive Protein and Peptides Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Bioactive Protein and Peptides Business of Rousselot (2019-2024)
    Table 50. Rousselot Recent Developments
    Table 51. BRF Ingredients Basic Information List
    Table 52. BRF Ingredients Description and Business Overview
    Table 53. BRF Ingredients Bioactive Protein and Peptides Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Bioactive Protein and Peptides Business of BRF Ingredients (2019-2024)
    Table 55. BRF Ingredients Recent Developments
    Table 56. Bunge Ltd Basic Information List
    Table 57. Bunge Ltd Description and Business Overview
    Table 58. Bunge Ltd Bioactive Protein and Peptides Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Bioactive Protein and Peptides Business of Bunge Ltd (2019-2024)
    Table 60. Bunge Ltd Recent Developments
    Table 61. Ingredia Nutritional Basic Information List
    Table 62. Ingredia Nutritional Description and Business Overview
    Table 63. Ingredia Nutritional Bioactive Protein and Peptides Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Bioactive Protein and Peptides Business of Ingredia Nutritional (2019-2024)
    Table 65. Ingredia Nutritional Recent Developments
    Table 66. Gelatines Weishardt Basic Information List
    Table 67. Gelatines Weishardt Description and Business Overview
    Table 68. Gelatines Weishardt Bioactive Protein and Peptides Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Bioactive Protein and Peptides Business of Gelatines Weishardt (2019-2024)
    Table 70. Gelatines Weishardt Recent Developments
    Table 71. PanTheryx Basic Information List
    Table 72. PanTheryx Description and Business Overview
    Table 73. PanTheryx Bioactive Protein and Peptides Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Bioactive Protein and Peptides Business of PanTheryx (2019-2024)
    Table 75. PanTheryx Recent Developments
    Table 76. Hubei Reborn Biotech Basic Information List
    Table 77. Hubei Reborn Biotech Description and Business Overview
    Table 78. Hubei Reborn Biotech Bioactive Protein and Peptides Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Bioactive Protein and Peptides Business of Hubei Reborn Biotech (2019-2024)
    Table 80. Hubei Reborn Biotech Recent Developments
    Table 81. Seagarden Basic Information List
    Table 82. Seagarden Description and Business Overview
    Table 83. Seagarden Bioactive Protein and Peptides Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Bioactive Protein and Peptides Business of Seagarden (2019-2024)
    Table 85. Seagarden Recent Developments
    Table 86. Shandong Hengxin Biotech Basic Information List
    Table 87. Shandong Hengxin Biotech Description and Business Overview
    Table 88. Shandong Hengxin Biotech Bioactive Protein and Peptides Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Bioactive Protein and Peptides Business of Shandong Hengxin Biotech (2019-2024)
    Table 90. Shandong Hengxin Biotech Recent Developments
    Table 91. Baotou Dongbao Bio-Tech Basic Information List
    Table 92. Baotou Dongbao Bio-Tech Description and Business Overview
    Table 93. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Bioactive Protein and Peptides Business of Baotou Dongbao Bio-Tech (2019-2024)
    Table 95. Baotou Dongbao Bio-Tech Recent Developments
    Table 96. Wuhan Jiushengtang Biotech Basic Information List
    Table 97. Wuhan Jiushengtang Biotech Description and Business Overview
    Table 98. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Bioactive Protein and Peptides Business of Wuhan Jiushengtang Biotech (2019-2024)
    Table 100. Wuhan Jiushengtang Biotech Recent Developments
    Table 101. Morinaga Milk Basic Information List
    Table 102. Morinaga Milk Description and Business Overview
    Table 103. Morinaga Milk Bioactive Protein and Peptides Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Bioactive Protein and Peptides Business of Morinaga Milk (2019-2024)
    Table 105. Morinaga Milk Recent Developments
    Table 106. Collagile Basic Information List
    Table 107. Collagile Description and Business Overview
    Table 108. Collagile Bioactive Protein and Peptides Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Bioactive Protein and Peptides Business of Collagile (2019-2024)
    Table 110. Collagile Recent Developments
    Table 111. Nuritas Basic Information List
    Table 112. Nuritas Description and Business Overview
    Table 113. Nuritas Bioactive Protein and Peptides Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Bioactive Protein and Peptides Business of Nuritas (2019-2024)
    Table 115. Nuritas Recent Developments
    Table 116. SmartPEP Basic Information List
    Table 117. SmartPEP Description and Business Overview
    Table 118. SmartPEP Bioactive Protein and Peptides Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Bioactive Protein and Peptides Business of SmartPEP (2019-2024)
    Table 120. SmartPEP Recent Developments
    Table 121. Key Raw Materials Lists
    Table 122. Raw Materials Key Suppliers Lists
    Table 123. Bioactive Protein and Peptides Downstream Customers
    Table 124. Bioactive Protein and Peptides Distributors List
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
    Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Bioactive Protein and Peptides Product Picture
    Figure 2. Global Bioactive Protein and Peptides Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Bioactive Protein and Peptides Sales Value (2019-2030) & (US$ Million)
    Figure 4. Bioactive Protein and Peptides Report Years Considered
    Figure 5. Global Bioactive Protein and Peptides Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Bioactive Protein and Peptides Revenue in 2023
    Figure 7. Bioactive Protein and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Plant Source Picture
    Figure 9. Animal Source Picture
    Figure 10. Global Bioactive Protein and Peptides Sales Value by Source (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Bioactive Protein and Peptides Sales Value Market Share by Source, 2023 & 2030
    Figure 12. Product Picture of Functional Food
    Figure 13. Product Picture of Dietary Supplements
    Figure 14. Product Picture of Personal Care
    Figure 15. Product Picture of Animal Nutrition
    Figure 16. Product Picture of Other
    Figure 17. Global Bioactive Protein and Peptides Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Bioactive Protein and Peptides Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Bioactive Protein and Peptides Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Bioactive Protein and Peptides Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Bioactive Protein and Peptides Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Bioactive Protein and Peptides Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Bioactive Protein and Peptides Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Bioactive Protein and Peptides Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Bioactive Protein and Peptides Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Bioactive Protein and Peptides Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Bioactive Protein and Peptides Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Bioactive Protein and Peptides Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Bioactive Protein and Peptides Sales Value (%), (2019-2030)
    Figure 30. United States Bioactive Protein and Peptides Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Bioactive Protein and Peptides Sales Value by Source (%), 2023 VS 2030
    Figure 32. United States Bioactive Protein and Peptides Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Bioactive Protein and Peptides Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Bioactive Protein and Peptides Sales Value by Source (%), 2023 VS 2030
    Figure 35. Europe Bioactive Protein and Peptides Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Bioactive Protein and Peptides Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Bioactive Protein and Peptides Sales Value by Source (%), 2023 VS 2030
    Figure 38. China Bioactive Protein and Peptides Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Bioactive Protein and Peptides Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Bioactive Protein and Peptides Sales Value by Source (%), 2023 VS 2030
    Figure 41. Japan Bioactive Protein and Peptides Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Bioactive Protein and Peptides Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Bioactive Protein and Peptides Sales Value by Source (%), 2023 VS 2030
    Figure 44. South Korea Bioactive Protein and Peptides Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Bioactive Protein and Peptides Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Bioactive Protein and Peptides Sales Value by Source (%), 2023 VS 2030
    Figure 47. Southeast Asia Bioactive Protein and Peptides Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Bioactive Protein and Peptides Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Bioactive Protein and Peptides Sales Value by Source (%), 2023 VS 2030
    Figure 50. India Bioactive Protein and Peptides Sales Value by Application (%), 2023 VS 2030
    Figure 51. Bioactive Protein and Peptides Industrial Chain
    Figure 52. Bioactive Protein and Peptides Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation

Description

Bioactive proteins and peptides are considered as important ingredients in functional foods, nutraceuticals and personal care. The roles of bioactive proteins and peptides include antioxidant, antimicrobial, antihypertensive, immunomodulatory and other biological activities.

The global market for Bioactive Protein and Peptides was estimated to be worth US$ 1695.8 million in 2023 and is forecast to a readjusted size of US$ 2706.1 million by 2030 with a CAGR of 6.9% during the forecast period 2024-2030

Global key players of bioactive protein and peptides include Gelita, Kerry Group, Vital Proteins, Rousselot, BRF Ingredients, etc. The top five players hold a share over 50%. North America is the largest market, has a share about 40%, followed by Europe, and Asia-Pacific, with share 30% and 20%, separately.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Bioactive Protein and Peptides, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Bioactive Protein and Peptides by region & country, by Source, and by Application.

The Bioactive Protein and Peptides market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioactive Protein and Peptides.

Market Segmentation